HCPCS M1232: HCV Antibody Test, Reactive Result - OpenPayer

Summary & Overview

HCPCS M1232: HCV Antibody Test, Reactive Result

HCPCS Level II code M1232 denotes a reactive hepatitis C virus (HCV) antibody test result. As a marker of prior exposure to HCV, a reactive antibody result typically triggers follow-up diagnostic testing and care coordination to determine active infection and next steps. Nationally, standardized coding for reactive serology results supports surveillance, follow-up testing workflows, and payment for laboratory services across payers.

Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise briefing on what M1232 represents clinically, how it fits into laboratory service lines and typical outpatient sites of service, and the practical implications for billing workflows. The publication highlights which payers are included in the analysis and notes availability of data elements.

This report provides benchmarks and policy-relevant context for billing and documentation associated with reactive HCV antibody testing, outlines common modifiers seen on claims, and describes typical downstream clinical pathways prompted by a reactive result (e.g., confirmatory RNA testing). Data not provided in the input are identified as unavailable. The intent is to clarify coding use and support consistent claim documentation across national payers.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareM1232HCPCS Level IIHCV antibodyserologylaboratorydiagnostic-testingreactive-resultoutpatient-labbilling

Billing Code Overview

HCPCS Level II code M1232 indicates that a patient receives an HCV antibody test with a reactive result. This code represents a documented laboratory outcome where screening for hepatitis C virus (HCV) antibodies yields a reactive finding.

Service Type: Laboratory diagnostic testing (serology)

Typical Site of Service: Outpatient laboratory or ambulatory clinic setting, including community health centers and physician office labs where point-of-care or sent-out HCV antibody testing is performed.

Data not available in the input.

Clinical & Coding Specifications

Clinical Context

A 32-year-old patient presents to a primary care clinic for routine screening after reporting a history of injection drug use and prior incarceration. The clinician orders a Hepatitis C virus (HCV) antibody test. The phlebotomy team collects a blood specimen; the specimen is processed by the clinic laboratory or sent to an external reference lab. The result returns reactive for HCV antibody, indicating prior exposure to HCV. Following a reactive antibody result, the clinical workflow typically includes: ordering a confirmatory HCV RNA (viral load) test, review of prior HCV testing and treatment history, assessment of liver disease risk (ALT, AST), counseling about transmission risk, and linkage to specialty care for RNA confirmation and treatment evaluation. Typical sites of service include outpatient primary care clinics, community health centers, public health clinics, sexually transmitted infection clinics, and laboratory collection sites.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when substantially greater work is required for specimen collection or documentation beyond usual for HCV antibody testing (rare for simple blood draw).
`23`	Unusual anesthesia

HCPCS M1378: Documentation of Medical Reason for Not Recommending 10-Year Follow-Up

HCPCS-M1453-PRE-OPERATIVE-VISUAL-ACUITY-BETTER-THAN-20-40

HCPCS M1453: Pre-operative Visual Acuity Better Than 20/40

HCPCS-M1210-HIGH-RISK-MEDICATION-ORDERS-NOT-ORDERED

HCPCS M1210: At Least Two High-Risk Medication Orders Not Ordered

HCPCS-M1362-PATIENTS-DIED-DURING-MEASUREMENT-PERIOD

HCPCS Level II M1362: Patients Who Died During the Measurement Period

HCPCS-M1449-SCHIZOPHRENIA-PSYCHOTIC-DISORDER-DIAGNOSIS

HCPCS M1449: Active Diagnosis of Schizophrenia or Psychotic Disorder

HCPCS-M1223-GLAUCOMA-PLAN-OF-CARE

HCPCS M1223: Glaucoma Plan of Care Documented

HCPCS-M1324-INTRAVITREAL-PERIOCULAR-CORTICOSTEROID-INJECTION

HCPCS M1324: Intravitreal or Periocular Corticosteroid Injection

HCPCS-M1289-TOBACCO-USER-NO-CESSATION-INTERVENTION

HCPCS M1289: Tobacco User Without Cessation Intervention

HCPCS-LEVEL-II-M1300-INFLUENZA-IMMUNIZATION-NOT-ADMINISTERED

HCPCS Level II M1300: Influenza Immunization Not Administered

HCPCS-M1397-PATIENTS-RECURRENCE-DISEASE-PROGRESSION

HCPCS M1397: Patients with Recurrence/Disease Progression

Showing 1–10 of 356

Taxonomy Code	Specialty	Notes
`207Q00000X`	Family Medicine	Primary care clinicians ordering routine HCV screening and follow-up.
`207L00000X`	Internal Medicine	Adult medicine clinicians who screen and coordinate confirmatory testing.
`208D00000X`	Gastroenterology	Specialty managing liver disease and HCV treatment evaluations after RNA confirmation.
`363LF0000X`	Laboratory Director	Clinical laboratory professionals responsible for performing or overseeing HCV antibody testing.
`2080P0207X`	Infectious Disease	Specialists involved in complex HCV cases or coinfection management.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`Z11.59`	Encounter for screening for other viral diseases	Used when HCV screening is performed in an asymptomatic patient without known exposure.
`Z72.51`	High-risk heterosexual behavior	Indicates risk factor prompting HCV screening in behavioral risk assessment.
`F11.20`	Opioid dependence, uncomplicated	Substance use disorders that increase risk for HCV and prompt screening.
`B18.2`	Chronic viral hepatitis C	Diagnosis used when chronic HCV infection is confirmed by RNA testing after a reactive antibody.
`R75`	Abnormal immunological findings in serum	Used to report reactive antibody tests pending confirmatory testing.
`Z22.52`	Carrier of viral hepatitis C	Used when a patient is known to carry HCV; may be applied after confirmatory testing.
`Z00.129`	Encounter for routine child health examination without abnormal findings	Example of a screening encounter context when HCV screening may be included in preventive services.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`86643`	Hepatitis C antibody; EIA (enzyme immunoassay)	Standard CPT for HCV antibody screening; often performed in conjunction with HCPCS-level reporting.
`87522`	Hepatitis C, RNA, quantification; nucleic acid (e.g., RT-PCR), quantitative	Confirmatory test performed after a reactive HCV antibody to detect active viremia.
`87521`	Hepatitis C, RNA, qualitative; nucleic acid (e.g., RT-PCR), qualitative	Alternative confirmatory assay to detect presence/absence of HCV RNA following a reactive antibody.
`83036`	Hemoglobin; glycosylated (A1c)	Often ordered concurrently for baseline metabolic assessment in patients considered for HCV therapy.
`80076`	Hepatic function panel (includes bilirubin, AST, ALT, alkaline phosphatase, albumin)	Baseline liver tests commonly ordered after a reactive HCV antibody to assess liver injury and guide management.

OpenPayer